8-K: Bellevue Life Sciences Acquisition Corp. Secures $75,000 Loan and Extends Business Combination Deadline

Sentiment:

8-K Filing


Bellevue Life Sciences Acquisition Corp. issued a $75,000 promissory note to a board member and extended its deadline to complete a business combination.

Delay expectedThe company has extended the deadline for completing a business combination from February 14, 2024, to May 14, 2024.

Summary

  • Bellevue Life Sciences Acquisition Corp., a blank check company, issued a $75,000 promissory note to Jun Chul Whang, a member of its Board of Directors.
  • The note is unsecured and non-interest bearing.
  • The principal is due on the earlier of August 9, 2024, or the date the company completes an initial business combination.
  • The note's principal will be forgiven if a business combination is not completed by the deadline, except for funds held outside the trust account.
  • The company also amended its charter to extend the deadline for completing a business combination to May 14, 2024.
  • The company deposited $60,000 into its trust account in connection with the extension of the business combination deadline to March 14, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral. While the company has secured a loan and extended its deadline, it also highlights the challenges in finding a suitable business combination target and the risk of liquidation.

Positives

  • The company secured a $75,000 loan to support operations.
  • The extension of the business combination deadline provides more time to find a suitable target.
  • The company has secured additional funding to extend the deadline.

Negatives

  • The promissory note is a debt obligation that must be repaid or forgiven.
  • The company is relying on extensions to complete a business combination, which may indicate challenges in finding a suitable target.
  • The need for extensions and additional funding may indicate a lack of progress in securing a business combination.

Risks

  • Failure to complete a business combination by the extended deadline will result in the liquidation of the company.
  • The company may face challenges in finding a suitable business combination target within the extended timeframe.
  • The promissory note represents a financial obligation that could impact the company's financial position if not forgiven.
  • The company is reliant on the sponsor to deposit funds to extend the deadline.

Future Outlook

The company is focused on completing a business combination by the extended deadline of May 14, 2024. If a business combination is not completed by this date, the company will liquidate.

Industry Context

The document reflects the typical challenges faced by SPACs in finding suitable acquisition targets within their initial timeframes. The extension of the deadline and the issuance of a promissory note are common strategies used by SPACs to maintain operations and continue their search for a target.

Comparison to Industry Standards

  • The $75,000 promissory note is a relatively small amount compared to the typical capital raised by SPACs, which often run into the millions or hundreds of millions.
  • The extension of the business combination deadline is a common occurrence in the SPAC market, as many SPACs struggle to find suitable targets within their initial timeframe.
  • The deposit of $60,000 into the trust account is a standard mechanism to extend the deadline, with the amount often calculated based on the number of outstanding shares.
  • Other SPACs such as Churchill Capital Corp IV (CCIV) and Social Capital Hedosophia Holdings Corp V (IPOE) have also faced similar challenges in finding suitable targets and have had to extend their deadlines.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Amendment to CharterThe company amended its charter to extend the deadline for completing a business combination to May 14, 2024.February 9, 2024Extends the company's operational life and provides more time to find a suitable target.

Related Party Transactions

  • The promissory note was issued to Jun Chul Whang, a member of the company's Board of Directors.

Stakeholder Impact

  • Shareholders are impacted by the extension of the deadline and the potential for liquidation if a business combination is not completed.
  • Creditors are impacted by the promissory note and the potential for repayment or forgiveness.
  • Employees are impacted by the uncertainty surrounding the company's future.

Next Steps

  • The company will continue to seek a suitable business combination target.
  • The company will need to complete a business combination by May 14, 2024, or liquidate.
  • The sponsor may need to deposit additional funds on March 14, 2024, and April 15, 2024, to further extend the deadline.

Key Dates

DateDescription
February 25, 2020The Corporation's original certificate of incorporation was filed.
January 20, 2021A Certificate of Validation of Certificate of Amendment was filed.
April 25, 2022An Amended and Restated Certificate of Incorporation was filed.
May 9, 2022An Amended and Restated Certificate of Incorporation was filed.
February 13, 2023An Amended and Restated Certificate of Incorporation was filed.
November 9, 2023Stockholders approved a proposal to extend the business combination deadline and a Certificate of Amendment to the Amended and Restated Certificate of Incorporation was filed.
February 9, 2024The promissory note was issued, the charter was amended, and $60,000 was deposited into the trust account.
February 14, 2024Original deadline for business combination, and first date for potential additional deposit.
March 14, 2024Extended deadline for business combination, and second date for potential additional deposit.
April 15, 2024Third date for potential additional deposit.
May 14, 2024Extended deadline for business combination.
August 9, 2024Maturity date of the promissory note if a business combination has not occurred.

Keywords

promissory note, business combination, acquisition, SPAC, deadline extension, trust account, financing

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.